Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  3SBio Inc. (ADR)    SSRX   US88575Y1055

3SBIO INC. (ADR)

 (SSRX)

1
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisionsForum 

3SBIO INC ADR : 3SBio Inc. To Report 2010 First Quarter Unaudited Financial Results on May 16, 2010

05/11/2010| 05:40am US/Eastern
Recommend:
0

SHENYANG, China, May 11 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (Nasdaq: SSRX) ("3SBio" or "the Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that it will release unaudited financial results for the first quarter ended March 31, 2010 on May 16, 2010 at 8:00pm (Eastern).

Following the earnings announcement, 3SBio's senior management will host a conference call at 5:00 am (Pacific) / 8:00 am (Eastern) / 8:00 pm (Beijing/Hong Kong) on May 17, 2010 to discuss its 2010 first quarter financial results and recent business activity.

    The conference call may be accessed using the dial-in numbers below:

    Conference ID: 74760426

    Local dial-in:
    China - landline 800 819 0121
    China - mobile 400 620 8038
    Hong Kong - 852 2475 0994

    International toll-free dial-in:
    Hong Kong 800 930 346
    United Kingdom 080 8234 6646
    United States 1 866 519 4004
    International toll dial-in: 65 6723 9381

A telephone replay will be available two hours after the call until May 24, 2010 at:

    International dial-in: +61-2-8235-5000
    United States dial-in: 1-866-214-5335
    Replay- Conference ID: 74760426

Webcast

A live webcast of the conference will be available on the investor relations page of 3SBio's website at http://bbs.3sbio.com/en/News/xinvestors.aspx and at http://tinyurl.com/3sbio2010Q1 . A replay of the webcast will be available within one hour after the conclusion of the call.

About 3SBio Inc.

3SBio Inc. is a leading, fully integrated biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, primarily in China. For more information, please visit 3SBio on the web at http://www.3SBio.com

    Investor Contacts

     Bo Tan
     Chief Financial Officer
     3SBio Inc.
     Tel:   +86-24-2581-1820
     Email: ir@3SBio.com

     Tom Folinsbee
     Director of Investor Relations
     3SBio Inc.
     Tel:   +852-8191-6991
     Email: ir@3SBio.com

SOURCE 3SBio Inc.

Recommend :
0
Partner Area
React to this article
 
Latest news on 3SBIO INC. (ADR)
04/25 3SBIO INC. (ADR): 3SBio Inc. Adjourns Extraordinary General Meeting of Sharehol..
04/15 3SBIO INC. (ADR): OrbiMed Advisors Announces Institutional Shareholder Services..
04/12 3SBIO INC. (ADR): Glass Lewis Recommends 3SBio Shareholders Vote against Manage..
04/09DJU.S. HOT STOCK FUTURES: Hot stocks to watch
04/09DJU.S. HOT STOCK FUTURES: Hot stocks to watch
03/143SBIO INC. (ADR): quaterly earnings release
02/08DJU.S. HOT STOCK FUTURES: Hot stocks to watch
02/08DJ3SBIO INC. (ADR): 3SBio Agrees to Be Taken Private for $350 Million
20123SBIO INC. (ADR): quaterly earnings release
2012DJADR REPORT: Shares End Higher Ahead of Fed Statement
Dynamic quotes  
ON
| OFF
Copyright © 2013 Surperformance. All rights reserved.